16.94
price down icon0.76%   -0.13
 
loading
Core Laboratories Inc stock is currently priced at $16.94, with a 24-hour trading volume of 520.78K. It has seen a -0.76% decreased in the last 24 hours and a +2.67% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $17.15 pivot point. If it approaches the $16.39 support level, significant changes may occur.
Previous Close:
$17.07
Open:
$17.16
24h Volume:
520.78K
Market Cap:
$790.50M
Revenue:
$502.79M
Net Income/Loss:
$23.71M
P/E Ratio:
33.88
EPS:
0.5
Net Cash Flow:
$6.35M
1W Performance:
-1.40%
1M Performance:
+2.67%
6M Performance:
-24.27%
1Y Performance:
-18.75%
1D Range:
Value
$16.78
$17.54
52W Range:
Value
$13.82
$27.95

Core Laboratories Inc Stock (CLB) Company Profile

Name
Name
Core Laboratories Inc
Name
Sector
Energy (256)
Name
Phone
31 20 420 3191
Name
Address
Strawinskylaan 913, Tower A Level 9, Amsterdam
Name
Employee
4,600
Name
Twitter
@corelabcompany
Name
Next Earnings Date
2023-04-27
Name
Latest SEC Filings
Name
CLB's Discussions on Twitter

Core Laboratories Inc Stock (CLB) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-30-23 Downgrade Citigroup Neutral → Sell
Apr-18-23 Downgrade BofA Securities Neutral → Underperform
Jan-09-23 Upgrade BofA Securities Underperform → Neutral
Oct-07-22 Upgrade Citigroup Sell → Neutral
Sep-26-22 Downgrade Morgan Stanley Equal-Weight → Underweight
Apr-18-22 Downgrade Piper Sandler Neutral → Underweight
Oct-18-21 Downgrade BofA Securities Neutral → Underperform
Jul-09-21 Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-14-21 Downgrade Citigroup Neutral → Sell
Dec-18-20 Downgrade JP Morgan Neutral → Underweight
Nov-11-20 Reiterated Cowen Market Perform
Oct-13-20 Upgrade BofA Securities Underperform → Neutral
Sep-29-20 Upgrade ABN Amro Sell → Hold
Jul-16-20 Downgrade Scotiabank Sector Outperform → Sector Perform
Apr-13-20 Upgrade Scotiabank Sector Perform → Sector Outperform
Mar-09-20 Downgrade BofA/Merrill Buy → Underperform
Mar-09-20 Downgrade Evercore ISI Outperform → In-line
Jan-31-20 Reiterated Cowen Market Perform
Jan-30-20 Resumed Johnson Rice Buy
Jan-14-20 Initiated Bernstein Mkt Perform
Jan-02-20 Downgrade Stifel Buy → Hold
Dec-31-19 Reiterated Cowen Market Perform
Jul-10-19 Upgrade BofA/Merrill Neutral → Buy
Feb-25-19 Upgrade Tudor Pickering Hold → Buy
Dec-19-18 Downgrade Credit Suisse Outperform → Neutral
Dec-11-18 Downgrade JP Morgan Overweight → Neutral
Nov-16-18 Upgrade Guggenheim Neutral → Buy
Nov-01-18 Upgrade ABN Amro Sell → Buy
Oct-29-18 Reiterated Cowen Market Perform
View All

Core Laboratories Inc Stock (CLB) Financials Data

Core Laboratories Inc (CLB) Revenue 2024

CLB reported a revenue (TTM) of $502.79 million for the quarter ending March 31, 2023, a +5.37% rise year-over-year.
loading

Core Laboratories Inc (CLB) Net Income 2024

CLB net income (TTM) was $23.71 million for the quarter ending March 31, 2023, a +143.62% increase year-over-year.
loading

Core Laboratories Inc (CLB) Cash Flow 2024

CLB recorded a free cash flow (TTM) of $6.35 million for the quarter ending March 31, 2023, a -69.10% decrease year-over-year.
loading

Core Laboratories Inc (CLB) Earnings per Share 2024

CLB earnings per share (TTM) was $0.50 for the quarter ending March 31, 2023, a +140.38% growth year-over-year.
loading
Core Laboratories N.V. provides reservoir description, and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates in two segments, Reservoir Description and Production Enhancement segments. The Reservoir Description segment comprises the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. This segment offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. It also provides proprietary and joint industry studies. The Production Enhancement segment includes services and products relating to reservoir well completions, perforations, stimulations, and production. This segment offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories N.V. was founded in 1936 and is based in Amsterdam, the Netherlands.
oil_gas_equipment_services TDW
$95.72
price up icon 2.68%
oil_gas_equipment_services VAL
$69.20
price up icon 2.10%
oil_gas_equipment_services CHX
$34.86
price down icon 0.43%
oil_gas_equipment_services NOV
$18.87
price down icon 0.42%
$127.97
price up icon 3.49%
oil_gas_equipment_services FTI
$26.59
price up icon 0.00%
Cap:     |  Volume (24h):